Biohacking mogul Bryan Johnson consumed a five-gram “heroic dose” of psilocybin mushrooms during a high-stakes livestream on Sunday in Oregon, attempting to validate psychedelics as a quantifiable longevity intervention. The five-and-a-half-hour broadcast, which attracted over 1.1 million viewers, served as a public clinical trial for Johnson’s “Blueprint” protocol, monitoring whether psilocybin can optimize nearly 250 wellness biomarkers, including brain connectivity, cortisol levels, and testosterone.
High-Tech Neuroimaging and the Quest for Biological Youth
Before ingesting the powdered mushrooms mixed with lemon juice—a technique known as “lemon tekking” to increase potency—Johnson deployed a $50,000 neuroimaging helmet. Developed by Kernel, a company Johnson founded, the device measured real-time brain activity to document the psychedelic’s impact on neural architecture. The experiment also included rigorous biological sampling, with Johnson collecting saliva and temperature readings throughout the session.
Johnson frames the experience as a frontier in anti-aging science. Following a previous session on November 9, he claimed the substance triggered a “more flexible, youthful nervous system,” citing physiological changes such as increased frequency of spontaneous erections as evidence of systemic rejuvenation. During the stream, Johnson posited that psychedelics could eventually play a fundamental role in standard longevity therapies.
A Star-Studded “Circus” of Tech Influence
The event transformed into a cultural spectacle, featuring a diverse roster of high-profile participants. Guests included Johnson’s 20-year-old son, Talmage—noted for previous blood-plasma exchange collaborations with his father—journalist Ashlee Vance, and Salesforce CEO Marc Benioff. The broadcast also featured a DJ set by Grimes and an appearance by David Friedberg, co-host of the All-In podcast.
However, the performance-heavy nature of the trip drew sharp criticism from the scientific and psychedelic communities. Rayyan Zafar, a researcher at Imperial College London’s Centre for Psychedelic Research, characterized the setup as “ego enrichment” rather than the “ego dissolution” typically sought in therapeutic settings. Zafar noted that the livestreaming environment likely hindered the introspective focus necessary for genuine psychological benefit.
Scientific Skepticism vs. Digital Narcissism
Critics were vocal about the potential for pseudoscience to overshadow clinical rigor. Jamie Wheal, author of Recapture the Rapture, dismissed the project as a “circus of self-indulgence” and “digital narcissism.” Similarly, Colette Schmitt, founder of Neurodelics and Decriminalize Nature Philadelphia, raised concerns about the lack of independent scientific oversight. Schmitt argued that packaging speculation as “suppressed longevity science” while funneling audiences toward unregulated supplement products undermines scientific literacy.
Conversely, some observers saw value in the public display. Journalist and former Vice host Hamilton Morris, who appeared on the stream, suggested that demystifying the psychedelic experience could reduce societal stigma. Morris argued that showing the beneficial potential of these substances to a mass audience serves a valid public interest.
The Intersection of Gene Expression and Commercial Interests
The discussion during the peak of Johnson’s trip pivoted toward the molecular impact of psychedelics. David Friedberg cited studies suggesting these compounds can alter gene expression profiles, potentially leading to rejuvenating effects. Amidst these scientific claims, Marc Benioff highlighted the commercial potential of the movement, jokingly suggesting a sponsorship for the sleep masks used during the session.
While Johnson did not explicitly pitch his “Blueprint” supplement line during the trip, the event’s massive reach coincided with increased social media advertising for his longevity products. As the session concluded with a DJ set by Grimes and reflections from Johnson’s father, Richard, the biohacker admitted the journey “demanded respect” and was “challenging.” The event underscores a growing trend where Silicon Valley’s elite attempt to merge ancient medicine with modern biohacking, often blurring the lines between clinical research and personal branding.
